FindTrial
Sign In

Botulinum Neurotoxin Type A

DRUG5 trials

Sponsors

DeNova Research, Presidio Ospedaliero Garibaldi-Centro, Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Technical University of Bern, University of Pennsylvania

Conditions

Acne VulgarisBlepharospasmBlepharospasm of Both EyelidsBlepharospasm of Left EyelidBlepharospasm of Right EyelidBlepharospasm, Benign EssentialBotulismBurning Mouth Syndrome

Phase 1

Study of the Drug B11-FC (Botulism Treatment)
Not yet recruitingNCT06580236
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationBotulism
Start: 2024-08-31End: 2025-03-30Target: 40Updated: 2024-08-30

Phase 2

Safety and Efficacy of the Use of Botox on Acne
TerminatedNCT00765375
DeNova ResearchAcne Vulgaris
Start: 2008-09-30End: 2008-12-31Updated: 2018-06-29
Botulinum Toxin in Burning Mouth Syndrome
CompletedNCT02964728
Presidio Ospedaliero Garibaldi-CentroBurning Mouth Syndrome
Start: 2015-11-30End: 2016-05-31Updated: 2016-12-07
DaxibotulinumtoxinA for Blepharospasm
Not yet recruitingNCT07489430
University of PennsylvaniaBlepharospasm, Blepharospasm, Benign Essential, Blepharospasm of Both Eyelids +2
Start: 2026-07-01End: 2028-12-31Target: 20Updated: 2026-03-24

Unknown Phase

Effectiveness of an Interprofessional Approach to the Treatment of Spasticity With Botulinum Toxin & Non-pharmacological Therapies
Not yet recruitingNCT07160699
Technical University of BernSpasticity
Start: 2025-10-01End: 2027-04-30Target: 30Updated: 2025-09-08